Literature DB >> 27848184

The initiation and effects of plasma contact activation: an overview.

Lisha Lin1,2, Mingyi Wu1, Jinhua Zhao3.   

Abstract

The plasma contact system sits atop the intrinsic coagulation cascade and plasma kallikrein-kinin pathway, and in vivo its activation contributes, respectively, to coagulation and inflammation mainly via two downstream pathways. This system has been widely investigated, its activation mechanisms by negatively charged surfaces and the interactions within its components, factor XII, prekallikrein and high molecular weight kininogen are well understood at the biochemical level. However, as most of the activators that have been discovered by in vitro experiments are exogenous, the physiological activators and roles of the contact system have remained unclear and controversial. In the last two decades, several physiological activators have been identified, and a better understanding of its roles and its connection with other signaling pathways has been obtained from in vivo studies. In this article, we present an overview of the contact pathway with a focus on the activation mechanisms, natural stimuli, possible physiological roles, potential risks of its excessive activation, remaining questions and future prospects.

Entities:  

Keywords:  Coagulation; Contact activation; Factor XII; Inflammation; Kallikrein–kinin

Mesh:

Substances:

Year:  2016        PMID: 27848184     DOI: 10.1007/s12185-016-2132-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  77 in total

Review 1.  Hageman factor, platelets and polyphosphates: early history and recent connection.

Authors:  J Caen; Q Wu
Journal:  J Thromb Haemost       Date:  2010-04-30       Impact factor: 5.824

2.  Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition.

Authors:  O D RATNOFF; J M ROSENBLUM
Journal:  Am J Med       Date:  1958-08       Impact factor: 4.965

3.  The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion.

Authors:  M Silverberg; S V Diehl
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

4.  Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.

Authors:  Albert Adam; Nicolas Montpas; David Keire; Anik Désormeaux; Nancy J Brown; François Marceau; Benjamin Westenberger
Journal:  Biomaterials       Date:  2010-04-27       Impact factor: 12.479

5.  Activation of the contact-phase system on bacterial surfaces--a clue to serious complications in infectious diseases.

Authors:  H Herwald; M Mörgelin; A Olsén; M Rhen; B Dahlbäck; W Müller-Esterl; L Björck
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

Review 6.  Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation.

Authors:  James H Morrissey; Sharon H Choi; Stephanie A Smith
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

7.  Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator.

Authors:  Zia Shariat-Madar; Fakhri Mahdi; Alvin H Schmaier
Journal:  J Biol Chem       Date:  2002-02-05       Impact factor: 5.157

8.  Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.

Authors:  Coen Maas; José W P Govers-Riemslag; Barend Bouma; Bettina Schiks; Bouke P C Hazenberg; Henk M Lokhorst; Per Hammarström; Hugo ten Cate; Philip G de Groot; Bonno N Bouma; Martijn F B G Gebbink
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

9.  Defective thrombus formation in mice lacking coagulation factor XII.

Authors:  Thomas Renné; Miroslava Pozgajová; Sabine Grüner; Kai Schuh; Hans-Ulrich Pauer; Peter Burfeind; David Gailani; Bernhard Nieswandt
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

10.  Are hemostasis and thrombosis two sides of the same coin?

Authors:  Robert W Colman
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  9 in total

1.  The evolution of factor XI and the kallikrein-kinin system.

Authors:  Michał B Ponczek; Aleksandr Shamanaev; Alec LaPlace; S Kent Dickeson; Priyanka Srivastava; Mao-Fu Sun; Andras Gruber; Christian Kastrup; Jonas Emsley; David Gailani
Journal:  Blood Adv       Date:  2020-12-22

Review 2.  Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence.

Authors:  Stephan Nopp; Daniel Kraemmer; Cihan Ay
Journal:  Front Cardiovasc Med       Date:  2022-05-12

Review 3.  Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial Surfaces.

Authors:  Benjamin Tillman; David Gailani
Journal:  Semin Thromb Hemost       Date:  2017-09-12       Impact factor: 4.180

4.  A compendium and functional characterization of mammalian genes involved in adaptation to Arctic or Antarctic environments.

Authors:  Nikolay S Yudin; Denis M Larkin; Elena V Ignatieva
Journal:  BMC Genet       Date:  2017-12-28       Impact factor: 2.797

Review 5.  The Mast Cell, Contact, and Coagulation System Connection in Anaphylaxis.

Authors:  Mar Guilarte; Anna Sala-Cunill; Olga Luengo; Moisés Labrador-Horrillo; Victoria Cardona
Journal:  Front Immunol       Date:  2017-07-26       Impact factor: 7.561

6.  A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.

Authors:  Ivan Ivanov; Anton Matafonov; Mao-Fu Sun; Bassem M Mohammed; Qiufang Cheng; S Kent Dickeson; Suman Kundu; Ingrid M Verhamme; Andras Gruber; Keith McCrae; David Gailani
Journal:  Blood       Date:  2018-12-27       Impact factor: 25.476

Review 7.  The rebirth of the contact pathway: a new therapeutic target.

Authors:  Priyanka Srivastava; David Gailani
Journal:  Curr Opin Hematol       Date:  2020-09       Impact factor: 3.218

8.  The blood fluke Schistosoma mansoni cleaves the coagulation protein high molecular weight kininogen (HK) but does not generate the vasodilator bradykinin.

Authors:  Qiang Wang; Akram A Da'dara; Patrick J Skelly
Journal:  Parasit Vectors       Date:  2018-03-14       Impact factor: 3.876

9.  The Toxicology of Native Fucosylated Glycosaminoglycans and the Safety of Their Depolymerized Products as Anticoagulants.

Authors:  Lisha Lin; Sujuan Li; Na Gao; Weili Wang; Taocui Zhang; Lian Yang; Xingzhi Yang; Dan Luo; Xu Ji; Jinhua Zhao
Journal:  Mar Drugs       Date:  2021-08-27       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.